Also, we evaluated by molecular modeling the charge distribution
among the three different toxins, which may be implied in their different potencies and selectivities. www.selleckchem.com/products/nutlin-3a.html We should also mention that in order to standardize the as yet confusing nomenclature of animal toxins, δ-AITX-Bcg1a and δ-AITX-Bcg1b were named following a nomenclature rationale recently proposed [17]. Forty B. cangicum specimens were collected on the northern coast of São Paulo State, Brazil, and the venom was obtained by electrical stimulation of animals as previously described [20]. The B. cangicum venom (approximately 150 mg) was fractionated by gel filtration chromatography using a Sephadex G-50 column (1.9 cm × 131 cm, GE Healthcare, Uppsala, Sweden), as described [19] and [23]. Pools of the neurotoxic fraction, eluted in the third peak (Fr III), were submitted to RP-HPLC chromatography in an ÄKTA Purifier machine (GE Healthcare, Uppsala, Sweden)
using a semipreparative CAPCELL PAK C-18, 10 mm × 250 mm (Shiseido Corp., Kyoto, Japan) column. Approximately 10 mg of the neurotoxic pool were fractionated (1 mg per run) by RP-HPLC. The HPLC conditions used were: 0.1% trifluoroacetic acid (TFA) in water (solvent A) and acetonitrile containing 0.1% TFA (solvent B). The separations were performed at a flow rate of 2.5 mL/min and a 10–60% gradient of solvent B over 40 min. The eluted peptides were monitored at UV 214 nm, as described [36]. The peaks eluted at 30.24 and 30.57 min,
respectively, were manually collected and lyophilized learn more or concentrated for further re-purifications [36]. Each of PI3K inhibitor these components were re-purified twice by employing isocratic condition at 29% of solvent B, in order to best fit the purified peptides to proper peak symmetry. After obtaining good peak symmetries suggesting high purity, molecular mass assessments by MALDI-Tof mass spectrometry were carried out. The peptide cangitoxin-II (CGTX-II) was purified as previously reported [35]. The protein contents of both the neurotoxic fraction and the pure peptide samples were estimated by the bicinchoninic acid (BCA) method (Pierce, Rockford, USA) following the manufacturer’s instructions. Analyses of pure peptides obtained in the previous step were performed on an Ettan MALDI-TOF/Pro (GE Healthcare, Uppsala, Sweden) equipped with 337 nm pulsed nitrogen laser under reflectron mode. The accelerating voltage was 20 kV. Matrix, α-cyano-4-hydroxycinnamic acid (Sigma–Aldrich Co., USA), was prepared at a concentration of 10 mg/mL in 1:1 CH3CN/0.1% TFA. External calibration was performed with [Ile7]-angiotensin III (m/z 897.51, monoisotopic, Sigma) and insulin (m/z 5734.49, average, Sigma). The sample solution (0.5 μL) dropped onto the MALDI sample plate was added to the matrix solution (0.5 μL) and allowed to dry at room temperature.